Diagnostic value of faecal calprotectin in paediatric age;Utilità diagnostica del dosaggio della calprotectina fecale in età pediatrica

Medico e Bambino

Volumn 28, Issue 4, 2009, Pages 239-242

  Canani, Roberto Berni ^a   Passaro, Maria ^a   Puzone, Cuono ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Faecal calprotectin; Gastroenterology; Inflammatory bowel diseases; Mucosal inflammation

Indexed keywords

CALGRANULIN;

DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ENTERITIS; GASTROINTESTINAL DISEASE; HUMAN; SENSITIVITY AND SPECIFICITY; SHORT SURVEY;

EID: 68949131161     PISSN: 15913090     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Itou H, Yao M, Fujita I, et al. The crystal structure of human MRP14 (S100A9), a Ca(2+)-dependent regulator protein in inflammatory process. J Mol Biol 2002;316:265-276
2. Doussiere J, Bouzidi F, Vignais PV. The S100A8/A9 protein as a partner for the cytosolic factors of NADPH oxidase activation in neutrophils. Eur J Biochem 2002;269:3246-3255 (Pubitemid 34748111)
3. Robinson MJ, Tessier P, Poulsom R, Hogg N. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J Biol Chem 2002;277:3658-3665 (Pubitemid 34953239)
4. Loomans HJ, Hahn BL, Li QQ, Phadnis SH, Sohnle PG. Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. J Infect Dis 1998;177:812-814
5. Damms A, Bischoff SC. Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases. Int J Colorectal Dis 2008;23:985-992
6. Berni Canani R, Rapacciuolo L, Romano MT, et al. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis 2004;36:467-470 (Pubitemid 41115450)
7. Berni Canani R, Romano MT, Terrin G, et al. Fecal calprotectin in a useful diagnostic tool in pediatric gastroenterology. Ital J Pediatr 2005;31:89-94.
8. Olafsdottir E, Aksnes L, Fluge G, et al. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 2002;91:45-50. (Pubitemid 34151218)
9. Campeotto F, Butel MJ, Kalach N, et al. High faecal calprotectin concentration in newborn infants. Arch Dis Child Fetal Neonatal 2004;89:F353-5. (Pubitemid 38869681)
10. Bruzzese E, Raia V, Gaudiello G, et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004; 20:813-819 (Pubitemid 39319237)
11. Papp M, Norman GL, Altorjay I, Lakatos PL. Utility of serological markers in inflammatory bowel diseases: gadget or magic? World J Gastroenterol 2007;13:2028-2036
12. Berni Canani R, de Horatio LT, Terrin G, et al. Combined use of non invasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2006;42:9-15. (Pubitemid 43061003)
13. Berni Canani R, Terrin G, Rapacciuolo L, et al. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis 2008;40:547-553